RNA Nanomedicines for Individualized Tumor Immunotherapy...

(22:17)

RNA Nanomedicines for Intravenous Injection: Control of Targeting Selectivity to the Organs

(11:41)

RNA Nanomedicines for Individualized Tumor Immunotherapy: Patient Trials

(16:41)

Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich Haas

(31:8)

Nanomedicines for gene and protein delivery

(1:10:8)

RNA Nanotherapeutics for Cardiovascular Disease - John Cooke, HMRI

(30:57)

RNA Circuits Transform Cells into Nanodevices, Nanomedicine, Nanotechnology

(17:24)

RNA Therapeutics: Going Beyond the Liver

(33:50)

Harnessing siRNA-Loaded Nanomedicine to Target HIV #hiv #nanomedicine #rna

(10:48)

The NanoAssemblr Spark: Robust low volume RNA-lipid nanoparticle formulation

(5:18)

Is RNA Medicine the Next Paradigm Shift? Precision NanoSystems and the CRS BNLF Local Chapter

(47:11)

The Importance of Precision for Controlling Assembly and Targeting of Nanomedicines

(16:21)

Optimisation of lipophilicity in model self-amplifying RNA vaccine polyplexes

(15:26)

Microfluidics in manufacturing of mRNA Nanomedicines | Heinrich Haas, BioNTech

(24:35)

RNA and me: from the origins of life and nanomedicine to building an RNA ecosystem

(55:47)

RNA Nanotechnology

(7:39)

RNA Nanotherapeutic for Atherosclerotic Vascular Disease (John Cooke, MD, PhD)

(29:56)

RNA‐Lipid Nanoparticles: A Robust and Potent Tool for Gene Knockdown and Expression...

(14:45)

B-SMART ALZHEIMER RNA NANOMEDICINE

(2:1econd)

RNA G-quadruplexes in pre-miRNAs: A new way in the target of nucleolin

(3:31)